PARALLEL IN VIVO AND IN VITRO MELANOMA RNAi DROPOUT SCREENS
Ontology highlight
ABSTRACT: To identify factors preferentially necessary to drive tumor expansion we performed parallel in vitro and in vivo negative selection shRNA screens. Melanoma cells harboring shRNAs targeting several DNA Damage Response (DDR) kinases had a greater selective disadvantage in vivo than in vitro, indicating an essential contribution of these factors during tumor expansion. In growing tumors, DDR kinases were activated following hypoxia. Correspondingly, depletion or pharmacologic inhibition of DDR kinases was toxic to melanoma cells, including those that were resistant to BRAF inhibitor, and this could be enhanced by angiogenesis blockade. These results reveal that hypoxia sensitizes melanomas to targeted inhibition of the DDR and illustrate the utility of in vivo shRNA dropout screens for identification of pharmacologically tractable targets.
ORGANISM(S): Homo sapiens
PROVIDER: GSE61826 | GEO | 2014/09/30
SECONDARY ACCESSION(S): PRJNA262511
REPOSITORIES: GEO
ACCESS DATA